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Abstract

Introduction

Calcium oxalate stone disease is the most
commonhuman urinary stone disease in the Western Hemisphere. To understand different aspects
of the disease, calcium oxalate urolithiasis
in
the rat is used as a model. Spontaneous calcium
oxalate urolithiasis
is very rare in rats . Thus
the disease is experimentally induced and the
rats are generally made hyperoxaluric either by
admtnistration of excess oxalate, exposure to
the toxin ethylene glycol, or various nutritional
manipulations . All the experimental models show
renal injury associated with crystal deposition.
Calcium oxalate crystals are in most cases intralumfnal in renal tubules and often attached to
the basal lamina of the denuded epithelium. Rat
renal papillary tips and fornices appear to be
the preferential
sites for the deposition of
large calcium oxalate calculi. Where urinary
supersaturation of calcium oxalate has been studted the crystal forming rat urines are shown to
have higher urinary supersaturation of calcium
oxalate than their controls. Oxalate metabolism
in the rat is nearly identical to that in humans.
Thus, in a number of respects, experimental calcium oxalate urolithiasis
in the rat is s imilar
to calcium oxalate stone disease in man.

Urolithiasis,
the precipitation
of salts in
urine, is a process commonto many animals including man. The precipitation
results in the formation of crystals which move freely and are
harmlessly excreted by the animal, or are retained in the urinary tract resulting in stone
disease . Thus crystalluria,
nephrolithiasis,
and
lower urinary tract stone disease are special
manifestations of urolithiasis.
Every individual
passes crystals of calcium phosphate and or calcium oxalate in the urine making crystalluria
the most commonform of urolithiasis
in man.
Urinary stone disease, on the other hand,
afflicts approximately l of 1000 individuals in
the United States. Importantly, seventy to
eighty per cent of these stones contain calcium
oxalate. In contrast to man, spontaneous urolithiasis is quite rare in rats, espe c ially the
calcium oxalate type. Nonetheless, because the
rat is the most easily available and commonly
used laboratory animal, a number of experimental
models have been developed for the study of calcium oxalate urolithiasis.
In this brief review
various aspects of calcium oxalate urolithiasis
in the rat, with reference to humans and other
mammals, will be discussed.
Oxalate Metabolism
In mammalsurinary oxalate is derived from
exogenous and endogenous sources [51]. In man
from 5 to 15 percent of urinary oxalate comes
from dietary sources [51 ,82,84,106] of which
three to five percent is derived from dietary
glyco lat e [46,84]. Absorption of oxal ate through
the intestine is dependent on the availability
of soluble oxalate because soluble forms are
more readily absorbed. Their absorption is inversely related to the amount of availab l e calcium to convert soluble to insoluble calcium
oxalate. Other factors influencing oxalate
absorption in humans are magnesium, iron, trace
metals [51,106] bile salts, and fatty acids in
the intestinal
luminal fluids. Oxalate is
chiefly absorbed by a passive, non-energy dependent, non-carrier mediated simpl e diffusion
process [4]. Some recent studies have shown
carrier mediated as well as active uptake of
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intr aper iton ea l or subcutaneous injections in
the rat, 50% to 70% of 14c labelled oxalate was
recovered in the urine, a significant amount was
found in the bone [19,52
and up to 1% converted
into CO2 [19,11 8] . When14
C oxalate was given to
rat s through a throat probe 25% was recovered in
urine and 73% in faeces [ 3]; within 30 minutes of
oral administration,
14c labelled oxalate was
cleared by the kidney and entered the bladder,
and 2 hours later present in the bone.
Eighty five percent of the oxalate found
in mammalian urine i s endogenously produced
[51,122]. Oxalate is a non-es se ntial end product
of metabolism and is excreted unchanged in the
urine. Thirt y to fifty percent of urinary oxalate
is derived from oxidative metabolism of ascorbic
acid and about 40% comes from glycine. Hydroxypro line, serine, tryptophan and aromatic amino
aci ds contribut e smaller amounts. While ascorbate,
glyoxylate, and gly collate are the immediate
precursors and ca n directly convert to oxalate,
the other precursors are metabolised to oxalate
via glyuxylate or glycoll ate. Glyoxylat e is
generally considered to be the major immediate
precursor.
In rat too, a conversion of known precursor s to oxalate has been demonstrated [17,52,
118] and glyoxylate and ascorbic acid metabolism
are s hown to be mainly re spons ible for the endogenous production of urinary oxalate, Citric
ac id also appears to be a s ignificant sour ce of
urinary oxal ate i n the rat [52]. Various amino
acids al so contribut e to rat urinary oxalate but
their importance as precursors most probably
depends upon their availability.
The importance
of amino acids as a source of urin ary oxalate in
the rat is indicated by the marked effec t of
protein inta ke on urinary oxal ate. Oxal ate excretion fell by 60% on a low protein diet and increased by over 100% with a hi gh protein diet
[52]. Similar l y when rat diet was supplemented
with 3% glycin e and 5.2 % hydroxypro line, faeces
and urine contained unexpectedly hi gh amount s of
oxalate.
The li ver pla ys a major role in oxalate
metaboli sm: major enzymes involved in oxalate
biosynthesis such as gly colic acid dehydrogenase
and glycolic acid oxidase, are restricted to
liv er both in ra t and man [93]. Intestinal mucosa
also plays a role in production of oxalate from
a variety of precursors. Ribaya and Gershoff [91]
incubated homogenates of rat inte sti nal mucosa
with various 14c labelled oxalate precursors and
measured th e amounts of radioactivity
recovered
as l4co 2 and 14c oxalate. Signifi cant amounts of
sodium l-14 c gl yoxal ate converted to 14c oxalate.
Great variation exi sts in oxalate concentrations of various body tissues. Humankidneys contain more oxalate (0.4 mg/100 g wet wt) on a wet
weight basis than other tissues [54]. Oxalate
concentration is higher in rat kidneys than in
human kidneys and oxalate in male ra t kidneys is
greater than in the female averaging 38.8 mg/ 100
g wet wt in males, and 31.l mg/100 g wet wt in
females [92]. A concentration gradi ent exists
between the renal cortex and papilla in man and
rat [48,49,123]. Rat renal papilla contains the
maximumamount of oxalate (16.2 mg/100 g wet wt),

oxalate in certain experimental systems. Pinto
and Paternain [89] demonstrated the presence of
an oxalate binding protein in the cytosol fra ctions of the brush border cells of human and
rabbtt intestinal mucosa. They hypothesized that
at low concentrations of oxalate, active binding
took place, whereas at higher concentrations
simple diffusion occurred. Dijkuizen et. al. [21]
demonstrated an energy dependent uptake of oxalate by membrane vesicles isolated from the bacterium Pseudomonas oxalaticus.
Approximately 15% of dietary oxalate in rats
is absorbed from the intestine , accounting for
about one third of the urinary oxalate [52].
Passive diffusion appears to be the main mechanism: intestinal
uptake of oxalic acid in creases
linearly with increasing concentration [4,9,78].
Caspary [9], using everted sacs from variou s
parts of the gut of female Wistar rats, showed
the highest uptake rates by colonic intestinal
tissues and lowest by duodenal tissue.
In contrast, Madorsky and Finlayson [78], using isolated, intact, washed segments of the gut of Harlan
male rats, showed the highest 14c oxalate absorption by jejunal segments and lowest by colonic
segments. Madorsky and Finlayson [78] also showed
that the initial rate of 14c oxalate absorp tion
by intestinal
segments was higher than absorption
after 5 minutes suggest ing that oxalate might
inhibit its own absorption or that the rapid intake of oxalate in the first five minutes was an
anomalous behaviour and an experimenta l artifact.
Oxalate absorption in the rat intestine is
a lso influ enced by the amount of calcium in luminal fluids. On a low calcium diet, a 30% to 50%
rise in urinar y excretion of oxalate has been
observed [51 ,52]. An inhibitory effect of calcium
on absorptio n of oxalic acid has al so been s hown
by using everted sacs of various segments of rat
int esti ne [9]. The influence of ca l cium i s explained by the decrease in avai l abl e absorbable
intraluminal oxalate due to formation of insoluble calcium oxalat e.
Intestinal absorption of oxalate in rats may
a lso be influenced by the presence of bile and
fatty acids [9,104]. Unabsorbed fatty acids bind
intraluminal ca lcium which decreas es the amount
of ca l c ium available for binding oxalate [ 82].
Also, bile salts may increase coloni c absorption
of oxalate by a non-s pecific alteration of mucosal permeability [9,2 3].
More than half of the dietary oxalate in man
or rat is destroyed by bacteria in the large
intestine and less than half of ingested oxalate
can be accounted for in the faeces and urine .
However, faecal excretion of oxalate is considerably higher in the rat than in man [51,52].
Though most rat fecal oxalate is derived from
dietary sources, small amounts may originate in
the liver [51]. Oxalate transported from plasma
to rat intestinal
lumen has been demonstrated.
Dobson and Finlayson [24] injected 14c labelled
oxalate into the femoral vein of nephrectomized
rats and recovered the label in various gut segments. In man about 90% of 14c oxalate injected
i~travenously is recovered in the urine within 48
hours and little or no activity is detected in
the faeces or respired air [25,5 3]. Following
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Table l.
Calcium Oxalate Urolithiasis
S.No. Strain and Sex Method of Induction
l.

2.
3.
4.
5.

Germ free Male,
Female
Sprague-Dawley
Male
Charles River
Male
Holtzman Male
Sprague-Dawle y
Male

Sprague-Dawley
Male

7.

Sprague-Dawley
Male

8.

Carworth Farms
Nelson CFN
Male, Female
Sprague-Dawley
Male, Femal e

9.

10.
l l.

12.
13.
14.
15.
16.
17.

Sprague-Dawley
Male
Wistar Male
Wistar Male
Sprague-Dawley
Male
Wistar Male
Wistar Male
Weanling
Sprague-Dawley
Male
Charles River
CDMale
Charles River
CD, Male
Female
Castrated

Response

Spontaneous

Bladder sto nes in 50% males and 2%
females .
Stones in bladder.

Spontaneous
Dail y intraperitoneal
injections
of 1% sodium oxalate
Sing le intraperitoneal
i nj ections of 2.5 % sodium oxalate
Sodium Oxalate in diet
Ammonium
Oxalate

6.

in Rat

in diet

Ammon
ium Oxalate and ammonium
chlorid e in diet
Intraperitoneal
or subcutaneous
implantation of potassium oxalate containing mini-osmotic
pumps
Single intraperitoneal
injection
of sodium oxalate in addition to
potassium oxalate in miniosmotic pumps
4% Diethy lene glyco l mixed in
food
Ethylene glycol or ethy l ene glycol and ammoniumchloride in
water at various concentrations

acid in diet

Low phosphate diet

(P 0.16 %)

Low phosphate diet

(P 0.07 %)

Pyridoxine deficient
3% glycine

diet+

Pyridoxine deficient

diet

43
88

After 2 wks crystals in renal cortex,
114
medulla, papilla.
Within 15 min of injection crystals in
57
renal cortex; later in all parts of kidney.
Within a week crystals in renal cortex,
42
within 4 to 6 wks stones at renal
papillary tips.
vJithin a week stones at renal papillary
tips, in fornices, and pelvis. Incidence
of sto ne formation increased with time.
Greater incidence of stone formation than
with ammoniumoxalate alone.
Crystal lur ia within a week, single and
63
twinned as well as aggregated crysta l s.
Crysta lluri a; after 6 wks crystals in
renal tubules; macroscopic crystalline
deposits (stones) in bladder.
In two year feeding study bladder stones
in male rats.

Within 3 days crystals on papillary tips,
few rats with crystals in renal tubule s.
Acidification increased severity of crystal
deposition. Males had crysta l s at all
concentrations of ethylene glycol while
females only at 1% or more.
1% ethylene glycol in water +
Crystalluria;
crysta l deposition in
a magnesium deficient diet
renal cortex, medulla and papi lla.
0.5 % ethylene glycol in water+
Crystalluria after 3 wks; after 4 wks
0.5 µgram Vitamine D once a day crysta l s in renal tubules, on papillary
by ga vage
surface; stones in pelvis, ureters, bladder.
Intra peritoneal injection of 2. 5 Within 24 hr crysta l s in renal tubules
g/kg 4-hydroxy-L-proline
crystal l uria.
3% glycolic

Ref.

63

117
77

103

85
108

Within 3 wks crystals in renal cortex,
11
medulla, papilla; stones in pelvis,
ureters, bladder.
Stones in pelvis in 9 wks and bladder
13
in 14 wks
Microstones in renal pelvis after
120
l O months.
Crystalluria;
in 6 wks stones on renal
papillary tips, in fornices, pelvis,
ureters, bladder.
Renal papillary tip encrustation,
stones
36
in pelvis, ureters, bladder. After 3
months mal es were most affected and females
l east affected; after 6 months all rats
had similar deposits.
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to the diet, or by intraperitoneally
injecting
them into the rat (Table l). Hyperoxaluria has
also been induced by other dietary manipulations
including pyridoxine-deficient
diets, low phosphate diets, and high protein diets.
Oxalate Induced Urolithiasis:
Repeated intraperitoneal
injections of
sodium oxalate into male Charles River rats on
regular Purina rat chow and water resulted in a
deposition of calcium oxalate crystals throughout the kidney [114]. Rats tolerated daily
repeated injections of about 50 mg/kg with very
few side effects. In a modification of this
method male Holtzman rats were injected with
various amounts of 0.22M sodium oxalate in 0.9 %
saline and the kinetics of calcium oxalate
nephrolithiasis
were studied [57]. The LOSOwas
R 2.5xlo-4 but no rat succumbed to l.lxlo-4.
l.lxlQ-4 moles of sodium oxalate resulted in
non-specific cytologic damage which resolved
24 hr post-injection.
At this dose, urine volume
increased 50% in the first 24 hours, and 80%
during the second 24 hours. By the 3rd day postinjection urine volume was normal. Renal tissue
calcium increased for the first 4 hours. Subsequently it subsided as a first order process.
It was concluded that most of the increased
calcium was derived from glomerular filtrate
and
precipitated as calcium oxalate crystals which
were virtually all intratubular.
We have used the sodium oxalate injection
method to study the pathogenesis of calcium
oxalate urolithiasis
in the rat. Male SpragueDawley rats received single injections of 3, 5,
7, or 9 mg of sodium oxalate per 100 g body
weight utilizing 0.22M sodium oxalate solution
in 0.9 % saline. The animals were sacrificed
from 15 min to 2 wks after injection, and their
kidneys were examined by light microscopy, and
scanning and transmission electron microscopy
[59,60,61 ,67]. Calcium oxalate crystals appeared
in the proximal tubules within 15 minutes of the
sodium oxalate injection in as low a dose as
3 mg/kg body weight. Crystals apparently moved
with urine flow as they were absent 72 hours
post-injection.
Within a week the kidney was
morphologically normal. The size, number, and
location of calcium oxalate crystals depended
on the amount of sodium oxalate injected and the
time interval after the injection. The papillary
tip and cortico-medullary junction were the preferential sites for crystal deposition after
longer periods of injections of higher doses of
sodium oxalate [59,61]. Tubular epithelium from
proximal tubule to the collecting ducts was
damaged. The damage depended on the amount of
sodium oxalate injected [59,60,61] and was
mostly restricted to the tubules containing the
crystals. The first noticeable change was seen
in the proximal tubules whose brush border was
distorted by clubbing of the microvilli and the
formation of blebs (Fig. la, b). Later, microvilli were lost from localized areas of the
brush (Fig. 2a, b). Epithelial cells contained
increased numbers of lysosomes, some of which
were autophagic vacuoles (Fig. 3). General
cellular necrosis was seen in all parts of the
nephron. Degenerative changes included swelling
of the mitochondria (Fig. 4), dilatation of

followed by medulla (6.12 mg/100 g wet wt), and
cortex (3.4 mg/100 g wet wt) [123].
Composition of Stones
Of the various aspects of urolithiasis,
the
presence of stone is the one element which most
commonlysymbolises stone disease.
All human
urinary stones consist of two basic components,
crystals and matrix [29,79]. In urinary stone
disease of man, up to 97% of the stone is crystalline,
the rest is proteinaceous matrix. The
crystalline
component may be cystine, uric acid,
mono and dihydrates of calcium oxalate, magnesium
ammoniumphosphate, various types of calcium
phosphates and urates, and other materials that
are excreted in urine in concentrations sufficient for precipitation.
In rats, stones also
consist of organic matrix and crystals [34]. The
crystalline
component of stones may be citrate,
mono and dihydrates of calcium oxalate, calcium
phosphate, magnesium phosphate, magnesium ammonium phosphate and other substances experimentally induced to precipitate
in the urine.
Studies of rat stone matrix are limited [8,34].
Phosphate stones contain 19 amino acids, with
glutamic acid being the most abundant and arginine, methionine, histidine,
cysteine and cystine
occurring in insignificant
amounts [10]. In
addition to amino acids, rat kidney stones contain glucose, fatty acids, and cholesterol,
but
lack hexosamine, uronic acid , sulphate, and
sialic acid [8].
Spontaneous Oxalate Urolithiasis

in Rat

Documented cases of spontaneous urinary
stone formation in rats are rare (Table l). Although renal calcium phosphate and/or ammonium
magnesium phosphate stones have been reported,
there are no reports of spontaneously formed
oxalate stones in the rat upper urinary tract.
Rarely, oxalate stones have been found in the
bladder. Of 100 male Sprague-Dawley rats in a
toxicity study, only 2 rats were found to have
oxalate calculi, and these were associated with
calcium carbonate and calcium or ammoniumphosphate [88]. Mixed calcium oxalate and citrate
bladder calculi were found in 50% of male germ
free rats on a semi-synthetic diet with a composition within the limits of dietary standards [43}
Genetically related conventional rats on the same
diet did not form any calculi. The calculus forming germ free rats had high urinary calcium, high
citrate,
high pH, and low urinary phosphate. The
tendency to form calculi disappeared and the
urinary values became similar to those of noncalculi forming rats on contamination of germ free
rats by intestinal
flora from the conventional
rats.
Experimentally Induced
Oxalate Urolithiasis
in Rats
To understand different aspects of the oxalate stone disease in humans, oxalate urolithiasis has been induced in the rat by various means.
The main mechanism is production of hyperoxaluria
by addition of oxalate or an oxalate precursor
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Fig. la. SEMof proximal tubular epithelium showing lateral membranefolds (F) of tubular cells and
microvillous brush border (MB). The brush border is distorted by the formation of large blebs (B)
projecting into the tubular lumen. Bar= 5 µm. lb. TEMof a section through the brush border and a
bleb similar to one seen in la. The bleb (8) has a diffuse cytoplasm which is continuous with the
cytoplasm of the cell. Bar= 1 µm.
rats twice a day for a period ranging 49 days to
10 months [20]. Calcium oxalate crystals were
found in all renal tubular segments as well as
in the interstitium . Regressive changes were
evident not only in tubular epithelium but also
in the glomerular epithel i um. Thickening of
glomerular and tubular epithelial basement membranes was described. The first crystals were
interpreted as deposited in phagolysosomes.
In a recent study [42] male Sprague-Dawley
rats were fed diets supplemented with sodium or
ammoniumoxalate and calcium or ammoniumchloride.
Rats were sacrificed at weekly intervals for six
weeks. The animals fed sodium oxalate had
initial deposition of calcium oxalate monohydrate crystals in cortex and cortico-medullary
junction. After six weeks crystals were preferentially deposited at the papillary tips. The
urine was more alkaline (pH 7.4) than those of
the controls (pH 6.9) and had crystals of
triple phosphate. Animals on a diet supplemented
with ammoniumoxalate had a more acidic urine
(pH 5.6 to 6. 2) and, depending on the amount of
added oxalate, renal or bladder stones. Renal
deposits were present either in the papilla or
the fornices . Supplementation of diet with
either calcium chloride or ammoniumchloride
resulted in the acidification
of the urine, but
calcium chloride resulted in lowering of urinary
oxalate probably because of oxalate binding in
the gut.

endoplasmic reticulum, cytoplasmic edema, and
vacuolation. Luminal cell membranes of degenerating cells appeared to have burst releasing their
contents into the tubular lumen (Fig. 4). Focally,
cells were sheared from the tubular basement
membrane (Fig. 5) contributing to the cellular
debris present in all parts of the nephron (Fig.
6). The papillary tip surface was badly damaged.
Its covering epithelium was lost exposing the
underlying basement membrane [61]. Crystals of
both calcium oxalate monohydrate and dihydrate
were identified by morphology. Calcium oxalate
monohydrate crystals were present as aggregates
of monoclinic prismatic plates while calcium
oxalate dihydrates appeared as tetragonal bipyramids present individually or in aggregates [60,
67]. Crystals were intraluminal in the nephron
and almost always associated with flocculent
eosinophilic material which stained positively
with periodic acid Schiff reaction, Alcian blue
and colloidal iron (Fig. 7). Transmission electron microscopy revealed the material associated
with calcium oxalate crystals (Fig. 8) to be
cellular debris consisting of membranes, vesicles,
and cellular organelles in various stages of
degradation (Fig. 6). Crystals were often found
attached to epithelial cells, and, in totally
denuded tubules, were attached to the basement
membrane [59,61].
In a chronic study, 1 ml of 2.5 % sodium
oxalate solution in 0.9 % saline was injected in
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In the experiments described above oxalate
was administered either through diet or intraperitoneal injection. Because the amount of food
consumed by individual rats may vary, such
methods can give inconsistent results. Methods
utilizing single injections have the serious
defect that they produce sudden, acute, overloading surges causing high supersaturations
of
urinary salts and transient crystalluria.
To
meet these objections we induced urolithiasis
in
rats by subcutaneously or intraperitoneally
implanting mini-osmotic pumps (Alza Corporation,
Palo Alto, CA) loaded with a saturated solution of
potassium oxalate [63,64]. Osmotic pumps deliver
their contents at a specific rate for a given
period of time. The urine of experimental animals
had abundant crystals of calcium oxalate, calcium phosphate, triple phosphate mixed with amorphous calcium phosphate, and an amorphous viscid
material which was mostly calcium phosphate. No
crystals were deposited in the kidney. A direct
correlation was evident between supersaturation
and crystalluria.
However, crystal number did not
correlate well with the degree of supersaturation.
In this respect the experimental results resembled
human crystalluria
[119]. Urinary oxalate levels
of experimental animals were higher than their
controls and this increase was proportional to
the increase in urinary supersaturation of calcium oxalate. Urinary calcium levels were not
significanlty
altered. One group of animals,
injected with sodium oxalate in addition to the
potassium oxalate containing osmotic pump, had
calcium oxalate stones in their bladder and their
kidneys had deposits of calcium oxalate crystals.
In this respect rats behaved like stone formers
who showed an increase in size and aggregation of
calcium oxalate crystals on addition of oxalate
to their diet. Lower inhibitory activity in stone
formers' urine was thought to be responsible for
this situation [97].

but were absent in female rats [107]. In a s1m1lar study, male Sprague-Dawley rats given ethylene glycol in the diet were shown to be more
susceptible to crystal deposition in kidney and
renal calculus formation than the female [5].
Male rats on diets containing over 0.2 % ethylene glycol showed renal calcium oxalate crystal
deposition and at 0.5 % or more ethylene glycol,
renal stones were produced. On the other hand in
female rats renal crystal deposition was limited
to those on 1% and 4% ethylene glycol and calculi
were found only at 4% ethylene glycol. The
earliest lesions showed tubular epithelial
necrosis. Crystals were deposited on the basement
membrane. The amount of deposited crystal was
proportional to the concentration of ethylene
glycol in diet.
Acidification of urine in conjunction with
administration of ethylene glycol increases the
severity and incidence of urolithiasis
[77,99] .
Whenrats drank water containing both ammonium
chloride and ethylene glycol, renal crystal
deposition appeared severe [77]. Kidneys were
enlarged and stippled with yellowish white flecks
on their outer surfaces. Acidification caused an
increase in deposits within renal papilla and on
papillary tips. In addition it resulted in the
deposition of calcium oxalate monohydrate rather
than a mixture of mono- and di hydrate [77].
Recently it was shown that when male Wistar
rats were given 0.5 % ethylene glycol in water in
addition to 0.5 microgram of vitamin D administered by gavage, 77.3 % of the rats produced
stones in the renal pelvis, ureter and bladder
[85]. Typical calcium oxalate monohydrate crystals were found in the dilated tubules whose
epithelium was partially destroyed. There was a
marked increase in the weight of the kidney. Both
urinary oxalate and calcium increased and renal
insuffi cie ncy was moderate. There were no deaths
during the four week experiment.
Induction of Oxalate Uroliathiasis
by Other
Oxalate Precursors
Other oxalate precursors used to induce
urolithiasis
are hydroxyproline [108, 109],
glycolic acid [11 ,12], and glyoxylic acid [81].
Hydroxyproline is directly converted into glyoxylate. Administration to male Sprague-Dawley
[108] and male Wistar rats [109] by intraperitoneal injection of 10 ml/kg rat body weight,
resulted in the deposition of calcium oxalate
crystals in the renal tubules. The volume and
weight of the kidneys doubled in 24 hours [108].
Calcium oxalate dihydrate crystals formed in the
first 2 hours and later transformed to thermodynamically stable calcium oxalate monohydrate
[108].
Glyoxylate and glycollate are immediate
precursors of oxalate and their administration
results in oxalate urolithiasis.
Three percent
glycolic acid administered in diet to male Wistar
rats resulted in calcium oxalate crystal deposition in kidneys and formation of uroliths up to
4 mmin diameter in renal pelvis, ureters and
bladder [ll ,12]. Crystals were present throughout the renal cortex and medulla.

Urolithiasis
induced by
Ethylene Glycol Administration
Ethylene glycol is one of the precursors of
oxalate and has long been known as the cause of
calcium oxalate crystal deposition in kidneys of
man and animals when it is accidentally or intentionally ingested. Glycoaldehyde, glycollate and
glyoxylate are on its metabolic pathway to oxalate
and carbon -dioxide [40,93,118]. Most of the
ingested ethylene glycol is eliminated unchanged
in the urine and the bulk of the rest is oxidised
to carbon-dioxide [40]. The amount of oxalate
excreted is dependent upon the animal species as
well as the dose. In albino rats only about 0.5 %
to 1. 1% of the dose has been shown to be converted
to oxalate. At a lower dose level of O.l g/kg
rat body weight given by subcutaneous injections,
23% of the ethylene glycol was converted to
carbon-dioxide while 35% was excreted in the
urine, with none of it converted to oxalate. At
l g/kg dose level about 1. 1% of the ethylene glycol converted to urinary oxalate.
Whena 1% solution of ethylene glycol was
given to male and female rats in drinking water
small oxalate calculi were produced in male rats
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Fig. 2a. TEMof a sec tion
through proximal tubular
epithe liu m showin g foca l l oss
of mi crovi ll i. M, intact
microvilli.
Bar= 2.5 µm.
2b. SEMof the luminal
surfac e of proxi mal t ubul ar
epithe li um showing areas
with microvi lli (M) surround ed
by areas of focal l oss of
microvi lli . Bar= 5 µm.

Pyridoxine Deficiency
and Oxalate Urolithiasis

glycolate has been shown to be a better precursor of oxalate as compared to glyoxylate or
glycine [ 100,101] . Thus the re as ons for pyridoxine deficienc y causing hyperoxaluria remain
undetermined . A more recent study has shown
that pyridoxine deficienc y results in a carrier
mediated oxalate transport in experimental rat s
as opposed to simple diffusion in control rats
[28]. Such a transport mechanism results in
enhanced intestinal
absorption of oxalate leading to hyperoxaluria.
Vitamin B-6 deficiency not only elevates
urinary oxalate but also urinary calcium [80],
and in creases the activity of neuraminidase
and other lysosomal enzymes [22]. Neuraminidase
removes sialic acid from the glycosaminoglycans
(GAGs)and GAGsare important inhibitors of

Pyridoxine (Vitamin B- 6) deficiency causes
hyperoxaluria and oxal ate urolithiasi s in the cat
[38] and rat [l], and may also be a sig nifica nt
etiological
f act or in the formation of human
oxal ate renal ca lculi [ 27,28 , 39] . Si nce pyr ido xine in the form of pyridoxal-5'-phosphate
act s as
a coenzyme for a number of transamina ses it was
specu l ated that transamination of glyoxylate to
glyc ine was reduced in pyr ido xi ne deficiency
resulting in an accumulation of glyoxylate and
it s subseq uent conversion t o oxalate [35, 38].
However, no increase was detected in glyo xyl ate
levels of heart muscles of pyridoxine deficient
rats [47], and in pyridoxine deficien cy ,
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crystalluria
and pelvic stones on a diet containing less than 0.7 % phosphate [120]. No calcium
deposits were found in renal medulla or papilla.
The urine showed marked hypercalciuria and became
highly supersaturated with respect to calcium
oxalate within one week of stay on the low phosphate diet.

crystallization
[94,95]. Urinary citric acid
levels decrease [35] which may be important because citric acid is a known inhibitor of calcium
oxalate crystallization
[83]. Urinary phosphorous
and uric acid levels are not known to be affected
by pyridoxine deficiency. Thus hyperoxaluria and
hypercalciuria,
in association with decreased
inhibitor activity, may cause oxalate urolithiasis in pyridoxine deficiency.
On a pyridoxine deficient diet, male Charles
River [l] and Wistar [80] rats formed calculi
generally restricted to the tubules of renal
medulla and papilla, and to renal papillary tips
and calyceal fornices although ureteral and bladder stones were sometimes present [l ,80]. The
calculi were mainly calcium oxalate monohydrate
with calcium oxalate dihydrate on the surfaces
and traces of calcium phosphate [1,123]. Parts of
the papillary tip stones extended into the ducts
of Bellini suggesting the stones originated in
collecting ducts from a lesion similar to
Randall's type II plaque [65,90, 123]. In addition,
submucosal crystals present on the lateral
aspects of rena 1 papil 1ae resemb1ed Randa11 ' s
type I plaque [90].
Kidney changes, in addition to the deposition of calcium oxalate crystals, included
increased weight with papillary swelling and transitional epithelial
hyperplasia as well as cortical tubular dilatations,
and epithelial
degeneration in those rats subjected to long periods of
pyridoxine deficiency. The crystals were
associated with a PAS positive substance and in
male Charles River and Wistar rats were predominantly intraluminal. Crystals deposited in the
kidneys of male rats of TAC:SD/NfBRstrain were
however, predominantly interstitial
[73]. It was
suggested that the crystals induced by a pyridoxine deficient diet originate in the renal interstitium and later move to a intraluminal position
[73].
Alteration of urinary pH affected the extent
of calcium oxalate deposition in pyridoxine deficient rats. More urinary stones of larger sizes
were formed at low urinary pH [l].

Development of Calculi upon Foreign Bodies
Regional fixation of a growing stone has
been hypothesized as necessary for the development of upper urinary tract stone disease [33,90}
Once a fixed nidus is formed the stone grows by
encrustation [69]. With this in mind Vermeulen
and his colleagues [115,116] developed a foreign
body model for the study of stone disease. They
implanted various types of foreign bodies in
urinary bladders of male rats and studied the
growth of the encrustation [115]. Paraffin
foreign bodies did not encrust, though they did
result in the formation of free lying stones in
the bladder. All other foreign bodies tested
encrusted and grew. Though the average pH was
6.8 the stones consisted of magnesium ammonium
phosphate. It was later found that male SpragueDawley rats deposited struvite on foreign bodies
whereas female Sprague-Dawley rats produced
apatite [77], and that stones of desired composition could be induced by manipulation of diet or
administration of a lithogen [6,76,77]. Addition
of ethylene glycol to the drinking water, or a
pyridoxine deficient diet resulted in the formation of calcium oxalate stones which morphologically resembled clinical stones and contained
both ca l cium oxalate monohydrate and dihydrate
crystals. Acidification of urine however, caused
the formation of pure calcium oxalate monohydrate
stones and also increased the rate of sto ne
growth [6,76,77]. As discussed earlier ethylene
glycol administration generally results in
crystal deposition in kidney tissue. Renal crystal deposition can however be avoided by limiting
ethylene glycol to approximately 0.75 % in the
drinking water [87].
Although zinc discs were used as a foreign
body for such studies, studying such stones by
microscopy is difficult
because zinc cannot be
sectioned. To overcome this, plastic foreign
bodies were introduced [69]. Oxalate stones on
plastic foreign bodies induced by ethylene glycol
were sectioned following decalcification
by EDTA
treatment and examined by light microscopy and
scanning and transmission electron microscopy.
The encrustation was joined to the foreign body
by a thin amorphous organic layer upon which
crystals of calcium oxalate nucleated. The crystals were surrounded by an amorphous limiting
coat, and the stone contained cellular debris .
Apparently, the deposition of an organic layer on
the foreign body was the initiating
step in the
formation of the crust and the stones grew by
confluent crystal growth and aggregation. The
matrix was acquired by adsorption of macromolecules on crystal surfaces and incorporation of
cellular debris. Crystals of calcium oxalate have
been shown to adsorb proteinaceous coat from
solutions in in vitro experiments [62,72] and
calcium oxalate crystals of urinary stones on

Low Phosphate Diet
It has long been known that a low phosphate
diet results in an increase in urinary calcium
and citrate leading to the formation of citrate
stones in both weanling and mature rats [105,112,
113]. While no significant change occurs in
urinary oxalate levels of rats on low phosphate
diets [13,52], recent studies have shown that a
low phosphate diet may result in the formation of
calcium oxalate urinary stones in rats. A
moderately low phosphate diet with high calcium/
phosphorus ratio (0. 16% P, 0.56 % Ca, 3.52 % Ca/P)
resulted in calcium oxalate urolithiasis
in male
Wistar weanling rats [13]. Renal papillae contained intratubular deposits of calcium oxalate
in addition to subepithelial plaques of calcium.
Urolithiasis became severe with time. After 14
weeks on the diet bladder stones were present
and renal pelvis had visible stones. The calculi
were composed mainly of calcium oxalate, with less
than 10% calcium citrate. Mature male SpragueDawley rats produced calcium oxalate dihydrate
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Fig. 5. TEMof a section through the thin loop
of Henle showing shearing of the epithelial cells
from their basal lamina (b). Bar= 2 µm.

Fig. 3. TEMof a section through proximal tubular
epithelial cell showing autophagic vacuol e with a
mitochondria (m). Bar= 0.5 µm.

Fig. 6. TEMof a section through a tubular lumen
with cel lul ar debris. The debris conta in s various
degenerating cellular organelles of which mitochondri a (m) are sti ll recognizable and contain
floccu l ent densities. Bar= l µm.
decalcification
form crystal ghosts and contain
organic material within crystal boundaries [66,
68].
Fig. 4. TEMof a section through luminal end of a
degenerating proximal tubular epithelial cell
showing swoll en mitochondria (m), cellul ar edema,
vacuolation, and dilation of endoplasmic reticulum (unlabelled arrows) . The luminal plasma membrane is broken at the apex and is releasing cellular contents i nto the tubular lumen (L).
Bar= 2.5 µm.

Magnesiumand Oxal ate Urolithiasis
That dietary magnesium depletion in rats
produces hypomagnesemia and hypomagnesuria [41,
121] , and causes deposition of calcium phosphate
in renal tubules has l ong been known [18,86,121].
Recent studies have shown that magnesium deficiency also enhances calcium oxalate renal
tubular deposition in rats on experimenta l
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Fig. 7. A section through the renal cortex
stained with colloidal iron at pH 2.5. The glomerulus (G) and the crystal associated debris
(unlabelled arrows) in tubular lumen are stained.
Bar=30µm

Fig. 8. TEMof a section through tubular lumen
containing decalcified calcium oxalate crys tal s
(C) or cellular debris (unlabelled arrows) which in
this micrograph consists of membranous vesicles.
Bar = 2 um.

hyperoxaluric protocol induced either by pyrodoxine deficiency [37] or by administration of
ethylene glycol [102,103]. Clinically low urinary
magnesium/calcium ratios are found in ca l cium
oxalate stone formers [55,74,111] and reduction
of stone recurrence in renal calcium oxalate
stone formers occurs on prophyla ctic treatment
with magnesium hydroxide [55,56]. The mechanism
by which magnesium exerts its beneficial effect
on urolithiasis
has been studied in vivo and in
vitro. Hyperoxaluric male Sprague-Hawley rats
given magnesium oxide, magnesium chloride, sodium
bicarbonate, or ammoniumchloride, were studied
[6]. At comparable urinary pH, magnesium oxide
was more efficacious than sodium bicarbonate in
preventing stone formation, and fewer stones were
formed on magnesium chloride than on ammonium
chloride, thus proving the beneficial effect of
magnesium independent of urinary pH. Magnesium
may provide protection by increasing the solubility of calcium oxalate [26,45], or magnesium/
calcium ratio [55], or by complexing with oxalate
[83] and making it unavailable for binding with
calcium.

[14,15,16,44]. Experimental l y, the relation
between hyperuricosuria and stone format ion has
been studied in male Wistar rats by inducing
urinary excretion of uric acid in the presence
of hyperoxaluria [50]. Hyperoxa luri a was induced
by adding ethylene glycol to drinking water of
rats in a daily dose of 0.8 %, and hyperuricosuria was induced by administering 2% oxonic
acid by a duodenal tube. Oxonic acid is a
spec ific blocker of uricase, the enzyme responsible for metabolism of uric acid to al lantoin
in rats. After thirty days, more calcium oxalate
calculi were seen in renal parenchyma, pelvis,
and fornices on a combined regimen of oxonic acid
and ethylene glycol than with ethylene glycol
alone and no oxalate crystals were seen on
oxonic acid treatment alone. Calciu m oxalate
deposition in renal parenchyma was associated
with tubular epithelial damage and more crystals
were seen in medulla than in cortex.
It has been suggested that sodium acid
urate, uric acid and calcium oxalate share
sufficient structural similarities
to allow
epitaxis [16,75] and that urate crystals act as
nucleation agents for heterogeneous crystal li zation of calcium oxalate. This mechanism of
facilitation
of calcium oxalate crystallization
by urate particles,
and the relevance of epitaxis
hypothesis has been questioned [31 ,32]. An
alternate hypothesi s is that uric acid may

Hyperuricosuria

and Oxalate Urolithiasis

Clinical studies have shown a positive correlation between hyperuricosuria and hyperuricemia, and calcium oxalate stone formation
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promote calcium oxalate stone disease by interfering with naturally occurring urinary inhibitors of calcium oxalate crysta l growth. It has
been shown that human urines containing more
urates have less inhibitors and the addition of
urate in vitro reduces and removal of urates
restores inhibitory activity [94,95].
Experimental Calcium Oxalate Urolithiasis
As A Model for Human
Calcium Oxalate Stone Disease

Morphologically, damage to the renal tubular
epithelium has been found in papillectomy specimens from a stone patient [65]. The presence of
Randall's plaques [90] in stone patients is also
suggestive of the involvement of renal injury in
the stone disease. What role does renal injury
play in the evolution of stone disease? Whether
the injury is primary and thus an initiating
factor, or secondary but capable of promoting
increased crystallization
or secondary with no
role whatsoever has not been resolved. These are
some of the questions still to be answered and
have been discussed in greater details in a
number of reviews [7,29,31,70,71,110].
The reaction of calcium oxalate crystals
with organic materials appears to be a generally
critical mechanism in attachment and growth.
With foreign body models as an example, no crystal-foreign body interplay exists until the
foreign body is covered with an organic film
[69]. Central too, is the fact that all experimentally induced or spontaneously formed calcium
oxalate crystals, when closely examined, will
have an organic coating [62]. In the construction of a stone, the organic coating, in conjunction with other organic materials forms a complex scaffolding. This material, the matrix,
may play a significant cementing role in the
genesis of stone. Indeed, one is hard put to
visualize a stone without matrix.
Experimental stone formation in the rat is
not as yet completely understood. Rat calcium
oxalate stone matrix has to be examined both
morphologically and biochemically. The important
topic of inhibitors has to be explored both in
the normal and stone forming rats. It may be
that an analysis of the reasons why rats are
resistant to calcium oxalate stone is a more
important point in understanding human stone
formation than is the experimenta l induction.
Further exploration of these questions will
le ad to a more comprehensive understanding of
human stone disease and will permit a study of
the elements needed for effective treatment.

in Rat

Although calcium oxalate stone formation is
not a spontaneous phenomenon in most experimental
animals, near identity in oxalate metabolism in
man and rat permit several strategies for experimental modelling of stones in the rat. The value
of such manipulation is that dissection of the
two key processes involved in stone formation,
that of nucleation as in the study of calcium
oxalate nephrolithiasis,
and growth as in the
study of encrustation of foreign bodies, is possible. Furthermore, study of these mechanisms of
stone formation over time gives a more dynamic
view than is possible in studying the human ston~
Virtually all experimental models employed utilize hyperoxaluria as the basic perturbation,
whether by administration of excess oxalate [57],
exposure to the toxin ethylene glycol [77], or
manipulation of nutrition as exemplified by pyridoxine deficiency [l] . Although the point is
debated as to whether hyperoxaluria or hypercalciuria is more important in human stone formation
[98], physical chemical constra int s are such that
calcium oxalate crysta l s in urine would more
readily form 1~ith small oxal ate excess than with
calcium [30,96,98], making the hyperoxaluric rat
a valuable model for ca l cium oxalate stone
disease.
The study of the interaction between the
formed calcium oxalate crystals and renal or urothelial tissues points in a direction important
for the understanding of attachment and retention
of crystals for, without such retention, stone
disease would not be possible [33] . With few
exceptions, renal crystal deposition in experimental systems are associated with cell injury
or necrosis [l,59,80,102,103].
Although damaged
cel l s can be i dentified at the earliest times
that crystals are formed, it is unclear whether
damage occurs prior or subsequent to the crystal
formation. In either case, crystals are often
found associated with cell debris and such debris
is a commoncomponent of human stones. Loss of
epithelial cells exposes the basement membrane
which may provide for crystal attachment (l,61,
123]. Such a crystal fixation to basement membrane or other structures in the absence of urinary obstruction would be essential for retention
and stone growth. The renal tubular damage has
also been implicated in human urinary stone
disease. Matrix substance A and TammHorsfall
mucoprotein both are associated with renal injury
and both are found in urinary stones and are present in greater concentrations in urines of stone
patients than normal individual s [7,58,70,71,110].
Urinary enzyme pattern of urinary stone patients
is suggesti ve of renal tubular damage [2].

Acknowledgments
This work was supported by National
Institute of Health Grant No. 20586-08.
References
l. Andrus SB, Gershoff SN, Faragalla FF, Prien
EL.(1960). Production of calcium oxalate renal
calculi in vitamin B-6-deficient rats, study of
the influence of urine pH. Lab. Invest. -2_,7-27.
2. Baggio B, GambaroG, Ossi E, Favaro S,
Borsatti A. (1983). Increased urinary excretion
of rena l enzymes in idiopathic calcium oxalate
nephrolithiasis.
J. Ural. fil, 1161-1162.
3. Bannwart C, Hagmaier V, Rutishauser G,
Seiler H. (1979). Absorption of oxalic acid in
rats by means of a 14c labelled method. Eur.
Ural. ~. 276-277 .
4. Binder HJ. (1974). Intestinal oxalate absorption. Gastroenterology §1_, 441-446.

769

S.R. Khan and R.L. Hackett
5. Blood FR. (1965). Chronic toxicity of ethy lene glycol in the rat. Fd. Cosmet. Toxicol. 3,
229-234.
6. Borden TA, Lyon ES. ( 1969). The effects of
magnesium and pH on experimental calcium oxalate
stone disease. Invest. Urol. §_, 412-422.
7. Boyce WH, King JS. ( 1963). Present concepts
concerning the origin of matrix and stones. Ann.
NewYork Acad. Sci . .!.Qi, 563-578.
8. Bunce GE, King GA. (1978). Isolation and
partial characterization
of kidney stone matrix
induced by magnesium deficiency in the rat. Exp.
Mol. Path. 28, 322-329.
9. Caspary WF. (1977). Intestinal oxalate
absorption. I. Absorption in vitro. Res. exp. Me.
l.Zl, 13-24.
10. Chow FHC, Hamar OW,Udall RH. (1973). Urinary
calculi matrices and urine polyelectrolytes.
Proc . Soc. Exp. Biol. Med. ill, 912-916.
ll. ChowFC, Dysart MI, Hamar OW,Udall RH.
(1975). Control of oxalate urolithiasis
by DLAlanine. Invest. Urol. 11, 113-116.
12. ChowFC, Hamar OW,Boulay JP, Lewis LO.
(1978). Prevention of oxalate urolithiasis
by
some compounds. Invest. Urol . .12_,493-495.
13. Coburn SP, Packett LV. (1962). Calcium,
phosphorus, and citrate interaction s in oxalate
urolithiasis
produced with a low-phosphoru s diet
in rats. J . Nutr. 76, 385-392.
14. Coe FL. (1978). Hyperuricosuria with calcium
oxalate stones, in: Nephrolithiasis,
pathogenesis
and treatment (ed.), Year Book Medica l Publishers,
Chicago, 95-115.
15. Coe FL, Kavalich AG. (1974). Hypercalciuria
and hyperurico s uria in patients with calcium
nephrolithiasis.
New Eng. J. Med. ill, 1344-1350.
16. Coe FL, Lawton RL, Goldstein RB, Tambe V.
(1975). Sodium urate accelerates precipitation
of ca lcium oxalate in vitro. Proc . Soc. Exp.
Biol. Med. .!i2_, 926-929.
17. Cook DA, Henderson LM. (1969). The formation
of oxali c acid from the side chain of aromatic
amino acids in the rat . Biochim. Biophys. Acta.
ill, 404-411.
18. Cramer W. (1932). Experimental production of
kidney lesions by diet. Lancet 223, 174-175.
19. Curtin CO, King CG. (1955). The metabolism
of ascorbic acid-J-cl4 and oxalic acid -cl4 in
the rat. J . Biol. Chem. fil, 539-548.
20. David H, Uerlings D. (1968) . Electron microscopic changes of kidney structure after chronical injections of sodium oxalate. Beitr. Path .
Anat . .J.1£,284-302.
21. Dijkuizen L, Groen L, Harder W, Lonings WN.
(1977). Active transport of oxalate by
Pseudomonas oxalaticus OCl. Arch Microbial . 115,
223-227.
22. Dipaolo RV, Speilvogel C, Kanfer JN. (1975).
Increased lysosomal hydrolase activity in kidney
and brain from the vitamin 86-deficient developing rat. Pediat. Res. 2_, 693-697.

23. Dobbins JW, Binder HJ. (1976). Effect of
bil e ac id s and fatty acids on the colonic absorption of oxalate. Gastroenterology ZQ, 1096-1100.
24. Dobson DM, Finlayson B. (1973). Oxalate
transport from plasma to intestinal
lumen in the
rat. Surg. Forum 24, 540-542.
25. Elder TD, Wyngaarden JB. (l 960). The biosynthesis and turnover of oxalate in normal and
hyperoxaluric subjects. J. Cline. Invest. 39,
ll 37-1344.
26. Elliott JS, Eusebio E. (1965). Calcium oxalate solubility:
the effect of inor ganic salts,
urea, crea tinine, and organic acids. Invest.
Urol. l, 72-76.
27. Faber SR, Feitler WW,Bleiler RE, Ohlson MA,
Hodges RE. ( 1963). The effects of an induced
pyridoxine and pantothenic acid deficiency on
excretion of oxalic acid and xanthurenic acid in
the urine. Am. J. Clin . Nutr. 11., 406-412.
28. Farooqui S, MahmoodA, Nath R, Thind SK.
(1981). Nutrition and urolithiasis:
Part I,
Intestinal absorption of oxalate in vitamin 86
deficient rats. Ind . J. Exp. Biol . .l.2_, 551-554.
29. Finlayson B. (1974). Renal lith ias is in
review. Urol. Clin. N. Amer. .l_, 181-212.
30. Finlayson B. (1978). Physicochemical aspects
of urolithiasis.
Kidney Intl. 11, 334-360.
31. Finlay son B, Khan SR, Hackett RL. (1984}.
Mechanisms of stone for mation - an overview.
Scannin g Electron Microsc. 1984; III: 1419-1425.
32. Finlayson B, NewmanRC, Hunter PT. (1984) .
A review : The role of urate and allopurinol in
sto ne disease. Presented at Vth Intl. Symp.
Urol. and Rel . Res., Garmisch-Part enkir chen,
FRG, April 1-5, 1984, in: Urolithiasis,
Plenum
Press, NY, in press.
33. Finlayson B, Reid F. (1978). The expectation
of free and fixed particles in urinary stone
disease. Invest. Urol . .12_,442-448.
34. Finlayson B, Vermeulen CW, Stewart EJ.
(1961). Ston e matrix and mucoprotein from urine.
J. Urol. 84, 355-363.
35. Gershoff SN. (1964). Vitamin 86 and oxalate
metabolism. Vitam. Horm. _IT, 581-589.
36. Gershoff SN. (1970). Production of urinary
calculi in vitamin 8-6 deficient male, female,
and castrated male rat. J. Nut. .l.QQ,117-122.
37. Gershoff SN, Andrus SB. (1961). Dietary
magnesium, calcium, and vitamin 86 and experimental nephropathies in rats: calcium oxalate
calcu li, apatite nephrocalcinosis. J. Nutr . 73,
308-316.
38. Gershoff SN, Faragalla FF, Nelson DA, Andrus
SB. (1959). Vitamin 8-6 deficiency and oxalate
nephroca lcinosis in the cat. Am. J. Med. 27,
72- 80.
39. Gershoff SN, Prien EL. (1960). Excretion of
urinary metabolites in calcium oxalate urolithiasis. Effect of tryptophan and vitamin 86 administration. Am. J. Clin. Nutr. ~ . 812-816.
40. Gessner PK, Parke DV, Williams RT. (196ll.
Studie s in deto xi cation, the metabolism of l4clabeled ethylene glycol. Biochem. J. ]_.'}_,482-489.
770

Experimental Urolithiasis

and HumanStone Disease

41. Gitelman HJ, Kukolu S, Welt LG. (1968}. The
influence of the parathyroid glands on the hypercalcemia of experimental magnesium depletion in
the rat. J. Clin. Invest. 47, 118- 126.
42. Gregory JG, Park KY, Burns T. (1984). The
interaction of urinary oxalate, calcium and pH
in renal calculus formation as demonstrated in a
rat model, in: Urinary Stone, Ryall R, Brockis
JG, Marshall V, Finlayson B (eds.), Churchi ll
Livingstone, NewYork, 355-362.
43. Gustafsson BE, NormanA. (1962). Urinary
ca cul i in germ free rats. J. Exp. Med. 116, 273284.
44. Gutman AB. (1968)". Uric acid nephrolithiasis.
Am. J. Med. 45, 756-759.
45. Hammarsten B. (1929). Calcium oxalate and its
so1ubility in the presence of inorganic salts
wit h special reference to the occurrence of oxalu r ia. C.R. Lab. Carlsberg .J..Z.,
1-85.
46. Harris KS, Richardson KE. (1980). Glycolate
in the diet and its conversion to urinary oxala te in the rat. Invest. Ural . .ul_, 106-109.
47. Hauschildt S, Rudolph R, Feldheim W. (1972).
Oxalatsoffwechsel und thiamin-pyridoxin-versorgung bei der ratte. Intl. J . Vit. Nutr. Res. 42,
457-467.
48. Hautmann RE, LehmanA, Osswald H. (1980).
Intrarenal cal cium and oxalate concentration
gradients in healthy and stone forming kidneys,
the renal papilla as the primary nucleation site,
in : Urolithiasis,
clinical and basic research,
Smith LH, Robertson WG,Finlayson B (eds.),
Plenum Press, NewYork, 509-515.
49. Hautmann RE, LehmanA, Komar S. (1980). Cal cium and oxalate concentrations in human renal
tissues: the key to the pathogenesis of stone
formation. J. Ural . ]11, 317-319.
50. Hering F, Bigalke KH, Lutzeyer W. (1980) .
Interaction of hyperuricuria and hyperoxaluria
on renal calcium oxalate stone formation. Adv.
Exp. Med. Biol. 122A, 99-107.
51. Hodgkinson, A. (1977). Oxalic acid in biology
and medicine. Academic Press, London.
52. Hodgkinson A. (1978). Oxalic acid metaboli sm
in rat. J. Nutr. ~.
1155-1161.
53. Hodgkinson A, Wilkinson R. (1974). Plasma
oxalate concentra tion and renal excretion of
oxalate in man. Cl in. Sci. Mal. Med. 46, 61-73.
54. Hodgkinson A, Zarembski PM. (1968}. Oxalic
acid metabolism in man: a review. Cale. Tissue
Res. .?., 115-132.
55. Johansson G, BackmanU, Danielson G,
Fellstrom S, Ljunghall S, Wikstrom B. (1980).
Biochemical and clinical effects of the prophylacti c treatment of renal calcium stone with
magnesium hydroxide . J. Ural. _11i, 770-774.
56. Johansson G, BackmanU, Danielson G,
Fellstrom S, Ljunghall S, Wikstrom B. (1981 ).
Prophylactic treatment with magnesium hydroxide
in renal stone disease, in: Urolithiasis,
clinical and basic research, Plenum Publishing Corporation, NewYork, 267-273.

57. Jordan WR, Finlayson B, Luxenberg M. (1978).
Kinetics of early time calcium oxalate nephro1ithiasis . Invest. Ural. ]2, 465-468.
58. Keutel HJ, King Jr., JS.(1964). Further
studies of matrix substance. A. Invest. Ural . .?_,
115-122.
59. Khan SR, Finlayson B, Hackett RL. (1979).
Histologic study of the early events in oxalate
induced intranephronic calculosis.
Invest. Ural.
lZ., 199-202.
60. Khan SR, Finlayson B, Hackett RL. (1979) .
Scanning electron microscopy of calcium oxalate
crystal formation in experimental nephrolithiasis. Lab. Invest . .!]_, 504-510.
61. Khan SR, Finla yson B, Hackett RL. (1982).
Experimental calcium oxalate nephrolithiasis
in
the rat, role of renal papilla. Am. J. Path. 107,
59-69.
62. Khan SR, Finlayson B, Hackett RL. (1983).
Stone matrix as proteins adsorbed on crystal
surfaces: a microscopic study. Scanning Electron
Mierase. 1983; I: 379-385.
63. Khan SR, Fin la yson B, Hackett RL. (1983}.
Experimental induction of crystalluria
in rats
using mini-osmotic pumps. Ural. Res. l!_, 199205.
64. Khan SR, Finlayson B, Hackett RL. (1984).
Relationship between experimenta ll y induced
crystalluria
and re lative supersaturation of
various stone salts in rats. Urol . Res. 12, 271273.
65. Khan SR, Finlayson B, Hackett RL. (1984).
Renal papi llar y changes in patient with cal cium
oxalate lithi asis. Urology 23, 194-199.
66. Khan SR, Finlayson B, Hackett RL. (1983}.
Agar-embedded urinary stones: a techn4que useful
for studying microscopic architecture.
J. Ural.
l]Q, 992-995.
67. Khan SR, Hackett RL. (1980). The use of SEM
in the study of oxalate induced experimental
nephrolithiasis.
Scanning Electron Microsc. 1980;
III: 379- 386.
68. Khan SR, Hackett RL. (1984). Microstructure
of decalcified human calcium oxalate urinary
stones. Scanning Electron Microsc . 1984; II:
935-941.
69. Khan SR, Hackett RL, Thomas Jr. WC,
Finlayson B. (1984). Kinetics of cal cium oxal ate
encrustation on plastic foreign bodies in rat
urinary bladders, in: Urinary Stone, Ryall R,
Brockis JG, Marshall V, Finlayson B (eds .),
Churchill Livingstone, NewYork, 363-371.
70. King Jr. JS. (1967). Etiologic factors involved in urolithiasis:
a review of recent
research. J. Ural.'}]_, 583-587.
71. King Jr . JS. ( 1971). Currents in renal stone
research. Clin. Chem. lZ., 971-982.
72. Leal JJ, Finlayson B. (1977}. Adsorption of
naturally occurring polymers onto calcium oxalate crystal surfaces. Inves . Ural . .J.i, 278-283.

771

S.R. Khan and R.L. Hackett
91. Ribaya JD, Gershoff SN. (1982). Factors
affecting endogenous oxalate synthesis and its
excretion in feces and urine in rats. J. Nutr.
ill, 2161-2169.
92. Richardson KE. (1965). Endogenous oxalate
synthesis in male and female rats. Toxic. Appl.
Pharmac. ]__,507-515.
93. Richardson KE, Farinelli MP. (1980). The
pathways of oxalate biosynthesis, in: Urolithiasis, clinical and basic research, Smith LH,
Robertson WG,Finlayson B (eds.), Plenum Press,
NewYork, 855-863.
94. Robertson WG. (1976). Physical chemical
aspects of calcium stone formation in the urinary tract, in: Urolithiasis Research, Fleisch H,
Robertson WG,Smith LH, Vahlensieck W, (eds.),
Plenum Press, NewYork, 25-39.
95. Robertson WG,Know
les F, Peacock M. (1976).
Urinary acid mucopolysaccharide inhibitors of
cal cium oxalate crystallisation,
in: Urolithiasis Research, Fleisch H, Robertson WG,Smith LH,
Vahlensieck W, (eds . ), Plenum Press, NewYork,
331-334.
9ti. Robertson WG,Nordin BEC. (1976). Physicochemical factors governing stone formation.
Scient. Found. Urol. l, 254-2 67.
97. Robertson WG,Peacock M. (1972). Calcium
oxalate crystalluria
and inhibitors of crystallization in recurrent renal sto ne-formers.
Clin. Sci. 43, 499-506.
98. Robertson WG,Peacock M. (1980). The cause
of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria. Nephron. .£§_, 105-110.

73. Lilien OM,HammondWS, Krauss DJ, Elbadawi
A, Schoonmaker JE. (1981). The microgenesis of
some renal calculi. Invest. Urol. ~. 451-456.
74. Ljunghall S, Waern AU. (1977). Urinary
electrolytes in renal stone formers and healthy
subjects. A population study of sixty year old
men. Scand. J. Urol. Neph. Suppl . .1}_, 55-75.
75. Lonsdale K. (1968). Humansto nes. Scie nce
ill, 1199-1207.
76. Lyon ES, Borden TA, Ellis JE, Vermeulen CW.
(1966). Calcium oxalate lithiasis
produced by
pyridoxine deficiency and inhibition with high
magnesium diets. Invest. Urol. i, 133-142.
77. Lyon ES, Borden TA, Vermeulen CW. (1966).
Experimental oxalate lithiasis
produced with
ethylene glycol. Invest. Urol. i, 143-151.
78. Madorsky ML, Finlayson B. (1977). Oxalate
absorption from intestinal
segments of rats.
Invest. Urol . .!_i, 274- 277.
79. Malek RS, Boyce WH. (1973) . Intranephronic
calculosis: its significance and relationships
to matrix in nephrolithiasis.
J. Urol. 109, 5515~.

-

80. McIntosh GH, Belling GB, Bulman FH. (1979).
Experimental oxalate urolith formation in rats.
Aust. J. Exp. Biol. Med. Sci.~.
251-259.
81. Melon JM, Thomas J, Pierre R. (1971). Glyoxyli c acid induced experimental calcium oxalate
lithi asis of rat, its prevention with succene mide. Therapie 26, 991-995.
82. MenonM, Mahle CJ. (1982). Oxalate metabolism and renal cal culi. J . Ural. ill, 148-151.
83. Meyer JL, Smith LH. (1975). Growth of calcium oxalate crystals, II. Inhibition by natural
urinary crystal growth inhibitors.
Invest. Urol.
11, 36-39.
84. Nath R, Thind SK, Murthy MSR,Talwar HS,
Farooqui S. (1984). Molecular aspects of idiopathic urolithiasis.
Malec. Aspects Med.]__, 1-176.
85. Okada Y, KawamuraJ, Kuo YJ, Yoshida 0.
(1984). Experimental model for calcium oxalate
urolithiasis,
in: Urinary Stone, Ryall R, Brockis
JG, Marshall V, Finlayson B. (eds.), Churchill
Livingstone, NewYork, 378-383.
86. Oliver J, MacDowellM, WhangR, Welt LG.
(1966). The renal lesions of el ectro l yte imbalance. IV. The intranephronic calcu lo sis of
experimenta l magnesium depletion. J. Exp. Med.
ill, 263-265.
87. O'Rear CE, Van't Riet B, Smith MJV. (1978).
The development of a test system for in hibition
of urinary oxalate lithiasis.
Invest. Urol. 16,
163-165.
88. Paterson M. (1979). Urolithiasis
in the
Sprague-Dawl ey rat. Lab. Animal s 11, 17-20 .
89. Pinto B, Paternai n JC. (1978). Oxalate
transport by the human smal1 intestine.
Invest.
Ural. ~. 502-506.
90. Randall A. (1940). The eti ology of primary
renal cal cul us. Intl. Abst. Surg. J__l, 209-236.

99. Rodriguez-Minon Cifuentes JL. (1977). Calcium oxalate lithiasis
and nephrocalcinosis
induced by ethylene glycol . Act. Ural. Espano.
l, 39-44.
100. Rafe AM, Chalmers AH, Edwards JB. (1976).
14C-oxalate synthesis from {u-14c) glyoxylate
and (l-14C) glycol l ate in isolated rat hepatocytes. Biochem. Med. li, 277-283.
101. Runyan TJ, Gershoff SN. (1965). The effect
of vitamin B6 deficiency in rats on the metabolism of oxalic acid precursors. J. Biol. Chem.
240, 1889-1892.
102. Rushton HG, Spector M. ( 1982). Effects of
magnesium deficiency on intratubular cal cium
oxalate formation and crystalluria
in hyperoxaluric rats. J. Urol. ill, 598-604.
103. Rushton HG, Spector M, Rodgers AL, Magura
CE. (1980). Crystal deposition in the renal
tubules of hyperoxaluric and hypomagnesemicrats.
Scanning Electron Microsc. 1980; III: 387-398.
104. Saunders DR, Sillery J, McDonaldGB. (1975).
Regional differences in oxalate absorption by
rat intestine.
Evidence for excessive absorption
by the colon in Steatorrhoea . Gut. li, 543-554.
105. Schneider H, Steenbock H. (1940). Calcium
citrate uroliths on a low phosphorus diet. J.
Ural. 43, 339- 344.
106. Smith, LH. (1981). Oxalate and Urinar y
Calculi. Proc. 8th Intl . Cong. Nephrol. Edited by

772

Experimental Urolithiasis

and HumanStone Disease

W. Zurukzoglu, et al., S. Karger, Basel,
Switzerland.
1179-1185.
107. Tanret P, Thomas J, Thomas E, Cottentot F.
(1962). Influence of sex on the formation of
calcium oxalate deposits in rat kidneys after
ethylene glycol administration.
C.R. Soc. Biol.
(Paris) 12§_, 1285-1287.
108. Tawashi R, Cousineau M, Sharkawi M. (1980).
Calcium oxalate crystal formation in the kidneys
of rats injected with 4-hydroxy-L-Proline.
Ural. Res. §_, 121-127.

122. Williams HE, Smith Jr . LH. (1972). Primary
hyperoxaluria, in: The metabolic basis of inherited disease, 3rd ed. , Stanbury JB, ~/yngaarden
JB, Fredrick son DS, (eds. ) , McGraw-Hi
11 , New
York, 196-219.
123. Wright RJ, Hodgkinson A.(1972). Oxalic acid ,
calcium and phosphorus in renal papilla of
normal and stone forming rats. Invest. Ural. 2_,
369-375.

109. Thomas J, Thomas E, Balan L, Guillan JC,
Melon JM, Monsaingeon A. (1971). Production of
experimental calcium oxalate lithiasi s by
hydroxyproline. C.R. Soc. Biol. ill, 264-268.
110. Thorne I, Resnick MI. (1983). Urinary macromolecules and renal 1ithiasis.
World J. Ural. 1,
138-145.
111. Tiselius HG, Almgard LE, Larsson L, Sorbo
B. (1978) . A biochemical basis for grouping of
patients with urol ithiasis.
Euro. Ural. 4, 242249.
112. Van Reen R, Indacochea N, Hess WC. (1959a).
Urolithiasis
in the rat, II. Studies on the
effect of diet on the excretion of calcium,
citric acid, and phosphate. J. Nutr. 69, 397-402.
113. Van Reen R, Lyon HW,Losee FL. (1959b).
Urolithiasis
in the rat, I . The influence of diet
on the formation and prevention of calcium
citrate.
J. Nutr. 69, 392- 396.

J.G. Gregory: Your rats, infused with potassium
oxalate through the osmotic pump form crystals,
but no renal deposits. Is this a dose related
phenomenon?
Authors: We did not investigate this point. All
of our experiments were done using a saturated
solution of potassium oxalate. In other experimental systems crystal deposition in renal
tissue is dependent on the amount of lithogen
used. For example changing the dose of ethylene
glycol results in various crystal locations and
by altering dosage one can induce crystal deposition either in the upper or in lower urinary
tract (Text Reference 87).
J.G . Gregory: Did ele ctron microscopy of the
animals so treated show any evidence by electron
microscopy of renal tubular injury?
Authors: The kidneys of these animal~ were
studied only by light microscopy which did not
reveal any overt cellular injury .
J .G. Gregory: Are you proposing that ca l cium
oxalate crysta l s, formed renally, injure the
renal tubules, producing a proteinaceous material
that leads to crystal aggregation and then stone
formation? If so, this is an hypothesis that
should be addressable by use of the osmotic pump
model in which increasing concentrations of
oxalate are added intravenously. Do you have
data to supplement this area? Against thi s
possibility,
is the observation of many hyperoxaluric patients who for months have passed
massive quantities of crysta l s and crystal aggregates without ever forming a rena l calculus an
observation that makes one certain that crysta l
production itself is an insufficient
stimu lu s for
stone formation?
Authors: There are a number of possibilitie s. As
you suggested, calcium oxalat e crystals formed
within the renal tubules may injure the tubular
epithelium and initiate stone formation. Alt ernatively, cellular debris from injured renal
epithelium, irrespective of the cause of the
injury, may provide nidi for heterogeneous nucle ation of crysta l s. Thus the crysta l s may induce
renal epithelial
injury and may also be initi ated
by it . Whether one or both mechanisms operate has
not been clearly established, nor is it known
whether they act independently or in conjuction.
The observation th at hyperoxaluric patients
pass massive quantities of crystals and crysta l
aggregates without ever forming a renal calculus,
in itself,
neither proves nor disproves the hypotheses mentioned above. Crysta lluri a is only an
indication of supersaturated bladder urine .
Experimental work mentioned in our paper has
shown that crystals may be present in the urine
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without ever being seen in the kidneys. In our
opinion, rena l injury increases the probability
of renal stone formation.
R. Tawashi: It i s fascinating that controlling
delivery rate of oxalate ion using the miniosmotic pump system has an effect on the site of
crysta lli zation and the nature of crysta l s
formed. Do you have evidence or any idea how the
control deliv ery rate of ca++ might have on
crystalluria?
Authors: The point you raised is an interesting
one. We have not yet stud ied the effect of controlled delivery rate of ca++ on crysta lluri a.
But we are planning some experiments with this
particular aspect of urolithiasis
in mind.
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